Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Substitution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103896816B details iridium-catalyzed synthesis offering high enantioselectivity and scalable production for pharmaceutical intermediates.
Novel carbapenem derivatives with extended half-life and broad-spectrum activity. Optimized synthesis routes for cost-effective pharmaceutical intermediate manufacturing.
Patent CN104529838A reveals high optical purity synthesis for haloxyfop intermediates reducing cost and pollution for reliable agrochemical intermediate supplier.
Novel copper-catalyzed route for tranylcypromine intermediates offers high ee values and cost-effective scaling for global pharmaceutical supply chains.
Patent CN102167674A details a mild iridium-catalyzed method for synthesizing optically pure 3-aryl sulfur-substituted propenes, offering significant supply chain advantages.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116730993A reveals a novel Ir-catalyzed route for Teranavir. Achieve high-purity HIV protease inhibitors with reduced steps and cost reduction in API manufacturing.
Patent CN109053637B details a high-yield route for chiral epoxy intermediates. Offers cost-effective scale-up for pest control manufacturers.
Novel two-step route for Remdesivir intermediate CN111205294A. Enhanced chiral purity, reduced cost, scalable manufacturing for global pharma supply chains.
Discover a novel chiral pool synthesis route for high-purity (S)-metolachlor. This patent analysis reveals cost-effective manufacturing strategies for agrochemical intermediates.
Novel preparation method for AHU-377 intermediates ensures high chiral purity and yield. Optimized supply chain for pharmaceutical manufacturing partners seeking reliable production.
Patent CN110691516A discloses advanced methods for synthesizing chiral pyrrolidones. This report analyzes cost reduction in herbicide manufacturing and supply chain reliability for global agrochemical producers.
Patent CN107286075A reveals efficient Pd-catalyzed route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN105085322A offers high selectivity route for AHU-377 intermediate. Reduces diastereomers, ensures supply continuity for LCZ696 production.
Novel patent CN105085322A offers high selectivity synthesis for AHU-377 intermediate ensuring supply chain reliability and cost reduction in pharmaceutical manufacturing.
Novel asymmetric substitution route for Dapoxetine intermediate. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Novel process for dexlansoprazole via trifluoroethanol substitution improves purity and scalability for API manufacturing supply chains.
Novel imidazolium-functionalized ferrocene ligands enable high-yield asymmetric allylic substitution with recyclable catalyst properties for pharmaceutical intermediates.
Patent CN102399163B reveals a high-yield 4-step route to Chloramphenicol using 4-chlorobenzaldehyde, eliminating resolution and reducing waste for reliable API intermediate supply.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.